Home  |  Contact
Due to scheduled maintenance work, this service will not be available from Tuesday August 23rd 06:00 pm until Wednesday August 24th 08:00 am CEST. Apologies for the inconvenience.

Cellosaurus NUGC-3/5-FU/L (CVCL_L502)

[Text version]

Cell line name NUGC-3/5-FU/L
Synonyms NUGC-3/5FU/L; NUGC-3/5-FU; NUGC-3/5FU
Accession CVCL_L502
Resource Identification Initiative To cite this cell line use: NUGC-3/5-FU/L (RRID:CVCL_L502)
Comments Part of: JFCR45 cancer cell line panel.
Population: Japanese.
Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
Omics: Transcriptome analysis.
Sequence variations
  • Mutation; HGNC; 11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (from parent cell line).
Disease Gastric adenocarcinoma (NCIt: C4004)
Derived from metastatic site: Brachialis muscle.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1612 (NUGC-3)
Sex of cell Male
Age at sampling 72Y
Category Cancer cell line

PubMed=8609072; DOI=10.1111/j.1349-7006.1996.tb03161.x
Inaba M., Mitsuhashi J., Sawada H., Miike N., Naoe Y., Daimon A., Koizumi K., Tsujimoto H., Fukushima M.
Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells.
Jpn. J. Cancer Res. 87:212-220(1996)

PubMed=10359051; DOI=10.1111/j.1349-7006.1999.tb00754.x
Inaba M., Sawada H., Sadata A., Hamada H.
Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction.
Jpn. J. Cancer Res. 90:349-354(1999)

PubMed=15767549; DOI=10.1158/1535-7163.MCT-04-0234
Nakatsu N., Yoshida Y., Yamazaki K., Nakamura T., Dan S., Fukui Y., Yamori T.
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
Mol. Cancer Ther. 4:399-412(2005)

Encyclopedic resources Wikidata; Q54931162
Entry history
Entry creation06-May-2013
Last entry update20-May-2021
Version number14